Susan Criswell, MD
Dr. Criswell is a fellowship trained Movement Disorder specialist with postdoctoral degree in clinical investigation. Her research interests are focused in evaluating environmental risk factors for parkinsonism. Specific intrestes include the use of PET and MRI and as a non-invasive biomarkers of neurotoxic exposures.
Areas of Clinical Interest
Movement disorders, botulinum toxin injections, dystonia, Parkinson's disease, Huntington's disease, Tourette Syndrome.
B.S.: Biological Sciences. University of Nebraska-Lincoln, Lincoln, Nebraska, 1997
Medical Degree:University of Nebraska Medical Center: M.D. May 2001
Residency: Neurology, Washington University School of Medicine, St. Louis, Missouri, 2005
Fellowship: Movement Disorders, Department of Neurology, Washington University at Barnes-Jewish Hospital, St. Louis, Missouri, 2007
MSCI: Washington University in St. Louis: MSCI. May 2009.
Honors and Awards
Alpha Omega Alpha, Honor Medical Society, University of Nebraska Medical Center, 2000
Criswell SR, Crowner BE, Racette BA. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy. Neurosurg Focus 2006; 21(2):e1.
Racette BA, Good LM, Kissel AM, Criswell SR, Perlmutter JS. A population-based study of parkinsonism in an Amish community. Neuroepidemiology 2009; 33(3):225-30.
Willis AW, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries. Neuroepidemiology 2010; 34(3):143-51.
Criswell SR, Sterling C, Swisher L, Evanoff BA, Racette BA. Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders. Parkinsonsim Relat Disord. 2010 Mar; 16(3):197-201.
Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced Uptake of [18F]FDOPA PET in Asymptomatic Welders with Occupational Manganese Exposure. Neurology 2011 Apr 12;76(15):1296-301.
Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced Uptake of [18F]FDOPA PET in End Stage Liver Disease with Elevated Manganese Levels. Arch Neurol 2012 Mar;69(3):394-7.
Harris RC, Lundin JI, Criswell SR, Hobson A, Swisher LM, Evanoff, BA, Checkoway H, Racette BA. Effects of Parkinsonism on Health Status in Welding Exposed Workers. Parkinsonism Relat Disord 2011 Nov;17(9):672-6.
Criswell SR, Perlmutter JS, Huang J, Golchin N, Flores HP, Aschner M, Erikson K, Checkoway H, Racette BA. Basal Ganglia Intensity Indices and Diffusion Weighted Imaging in Manganese Exposed Welders. Occup Environ Med 2012 Jun;69(6):437-43.
Nelson G, Criswell SR, Zhang J, Murray J, Racette BA. Research capacity development in South African manganese mines to bridge exposure and neuropathologic outcomes. Neurotoxicology 2012 Aug;33(4):683-6.
Racette BA, Aschner M, Guilarte TR, Dydak U, Criswell SR, Zheng W. Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology 2012 Aug;33(4):881-6.
Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology 2012 Sept 3 [Epub ahead of print]
© 2006-2012 Washington University School of Medicine